Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  238,391 results for ""VACCINES""

Your Filters

Filter by : Subject Content Provider : MEDLINE
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Recent progress and major gaps in the vaccine development for African swine fever.

  • Authors : Chandana MS; Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Uttar Pradesh, Izatnagar, Bareilly, 243 122, India. .; Nair SS

Subjects: African Swine Fever*/African Swine Fever*/African Swine Fever*/prevention & control ; African Swine Fever*/African Swine Fever*/African Swine Fever*/epidemiology ; African Swine Fever Virus*/African Swine Fever Virus*/African Swine Fever Virus*/genetics

  • Source: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] [Braz J Microbiol] 2024 Mar; Vol. 55 (1), pp. 997-1010. Date of Electronic Publication: Publisher: Springer International Publishing Country of Publication: Brazil NLM ID: 101095924 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Approaches of dengue control: vaccine strategies and future aspects.

  • Authors : Akter R; Department of Pharmacy, Independent University Bangladesh, Dhaka, Bangladesh.; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.

Subjects: Dengue* ; Dengue Virus*/Dengue Virus*/Dengue Virus*/genetics ; Dengue Vaccines*

  • Source: Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1362780. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

CHO cells for virus-like particle and subunit vaccine manufacturing.

  • Authors : Sanchez-Martinez ZV; Human Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC H4P 2R2, Canada; Department of Biochemistry and Molecular Medicine, University of Montreal, Montreal, QC H3T 1J4, Canada.

Subjects: Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/prevention & control ; Respiratory Syncytial Virus, Human* ; Vaccines, Virus-Like Particle*

  • Source: Vaccine [Vaccine] 2024 Apr 11; Vol. 42 (10), pp. 2530-2542. Date of Electronic Publication: 2024 Mar 19.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.

  • Authors : Yadegarynia D; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Keyvanfar A

Subjects: Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects ; Influenza A Virus, H1N1 Subtype* ; HIV Seropositivity*

  • Source: Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2254-2259. Date of Electronic Publication: 2024 Feb 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database.

  • Authors : Woo HG; Department of Neurology, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.; Kim HJ

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/epidemiology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/etiology ; Viral Vaccines*

  • Source: Journal of medical virology [J Med Virol] 2024 Apr; Vol. 96 (4), pp. e29591.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

Read More Add to Saved list
×
Academic Journal

Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response.

  • Authors : Qi H; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China. .; Newish Biological R&D Center, Wuxi, China. .

Subjects: Vaccines, DNA*/Vaccines, DNA*/Vaccines, DNA*/genetics ; Papillomavirus Vaccines*/Papillomavirus Vaccines*/Papillomavirus Vaccines*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: Molecular cancer [Mol Cancer] 2024 Mar 08; Vol. 23 (1), pp. 46. Date of Electronic Publication: 2024 Mar 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis.

  • Authors : Censi S; Department of Neuroscience, Imaging and Clinical Sciences, 'G. d'Annunzio' University of Chieti-Pescara, Via Luigi Polacchi 11, 66100, Chieti, Italy.; Bisaccia G

Subjects: Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects ; Guillain-Barre Syndrome*/Guillain-Barre Syndrome*/Guillain-Barre Syndrome*/epidemiology ; Guillain-Barre Syndrome*/Guillain-Barre Syndrome*/Guillain-Barre Syndrome*/etiology

  • Source: Journal of neurology [J Neurol] 2024 Mar; Vol. 271 (3), pp. 1063-1071. Date of Electronic Publication: 2024 Jan 17.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Advances and prospects of mRNA vaccines in cancer immunotherapy.

  • Authors : Liu Y; NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China; Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China.

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/genetics ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; Uterine Cervical Neoplasms*

  • Source: Biochimica et biophysica acta. Reviews on cancer [Biochim Biophys Acta Rev Cancer] 2024 Mar; Vol. 1879 (2), pp. 189068. Date of Electronic Publication: 2024 Jan 01.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9806362 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.

  • Authors : Lee K; Department of Pediatrics, Chung-Ang University Hospital, Seoul, South Korea.; Lee H

Subjects: Anaphylaxis*/Anaphylaxis*/Anaphylaxis*/etiology ; Anaphylaxis*/Anaphylaxis*/Anaphylaxis*/chemically induced ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 690-701. Date of Electronic Publication: 2023 Dec 10.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Infertility: A common target of antivaccine misinformation campaigns.

  • Authors : Smith TC; College of Public Health, Kent State University, Kent, OH, United States. Electronic address: .; Gorski DH

Subjects: Abortion, Spontaneous* ; Communication* ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Vaccine [Vaccine] 2024 Feb 06; Vol. 42 (4), pp. 924-929. Date of Electronic Publication: 2024 Jan 19.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  238,391 results for ""VACCINES""